POSTERS ESMO 2024

Cáncer de mama

Cáncer de mama temprano

Personalized treatment approaches with HER2DX in early HER2-positive breast cancer: a precision tool for treatment decision-making.

Personalized treatment approaches with HER2DX in early HER2-positive breast cancer: a precision tool for treatment decision-making.

Poster Bd #: 280P

Poster

Descargar poster

Autor
Marta Tapia Céspedes

Hospital Clínico Universitario de Valencia

Compartir:

Una iniciativa científica de:

eco clover

Con el patrocinio de:

REGENERON